BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/13/2025 6:51:08 AM | Browse: 13 | Download: 61
 |
Received |
|
2025-07-17 12:23 |
|
Peer-Review Started |
|
2025-07-17 12:23 |
|
First Decision by Editorial Office Director |
|
2025-08-19 09:55 |
|
Return for Revision |
|
2025-08-19 09:55 |
|
Revised |
|
2025-09-02 13:26 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-13 02:50 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-13 03:18 |
|
Articles in Press |
|
2025-10-13 03:18 |
|
Edit the Manuscript by Language Editor |
|
2025-10-14 09:01 |
|
Typeset the Manuscript |
|
2025-10-30 09:38 |
|
Publish the Manuscript Online |
|
2025-11-13 06:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Expanding the role of radiomics and artificial intelligence in the management of inflammatory bowel disease: Insights, opportunities, and challenges
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zhi-Gang Liu and Shan-Shan Xie |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shan-Shan Xie, Professor, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Binjiang District, Hangzhou 310052, Zhejiang Province, China. sxie@zju.edu.cn |
| Key Words |
Radiomics; Artificial intelligence; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Secondary loss of response; Infliximab; Precision medicine; Machine learning; Disease monitoring |
| Core Tip |
Radiomics and artificial intelligence are emerging as powerful tools in the management of inflammatory bowel disease, particularly in predicting secondary loss of response to biologic therapies like infliximab. By integrating imaging data with clinical and laboratory parameters, these technologies offer a more personalized, proactive approach to disease management, enabling earlier interventions and optimizing treatment plans for both Crohn’s disease and ulcerative colitis. While challenges remain in standardization and clinical adoption, the potential to transform inflammatory bowel disease care with precision medicine is significant. |
| Publish Date |
2025-11-13 06:51 |
| Citation |
Liu ZG, Xie SS. Expanding the role of radiomics and artificial intelligence in the management of inflammatory bowel disease: Insights, opportunities, and challenges. World J Gastroenterol 2025; 31(42): 112107 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i42/112107.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i42.112107 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
